BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3152690)

  • 21. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
    Coulombe M; Yang H; Wolf LA; Gill RG
    J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of class II major histocompatibility antigens on thyroid, adult pancreatic islet, and fetal proislet allografts.
    Warren HS; Hodder MJ; Allan W; Hume DA; Simeonovic CJ
    Transplantation; 1992 Apr; 53(4):834-40. PubMed ID: 1566350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4 T cells and allograft rejection.
    Hao L; Wang Y; Gill RG; Lafferty KJ
    Transplant Proc; 1988 Feb; 20(1):56-60. PubMed ID: 2449753
    [No Abstract]   [Full Text] [Related]  

  • 25. Separation of T cell subsets following the injection of UV-irradiated alloantigen in vivo; failure of the lymphokine-dependent subset to reject cultured islet allografts.
    Bellgrau D; Hawkins G; Babcock S; Prowse S
    Transplant Proc; 1987 Feb; 19(1 Pt 1):310-2. PubMed ID: 3152702
    [No Abstract]   [Full Text] [Related]  

  • 26. Cell-mediated hyperacute rejection. IV. Lyt markers and adoptive transfer.
    Eichwald EJ; Jorgensen C; Graves G
    J Immunol; 1982 May; 128(5):2373-4. PubMed ID: 6977593
    [No Abstract]   [Full Text] [Related]  

  • 27. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
    Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
    Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H-40, an antigen controlled by an Igh-linked gene and recognized by cytotoxic T lymphocytes. II. Recognition of H-40 as a tumor antigen in leukemic animals.
    Henderson LA; Ciavarra R; Riblet R; Forman J
    J Immunol; 1984 Nov; 133(5):2778-85. PubMed ID: 6434638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine cardiac allograft survival following treatment of recipients with monoclonal anti-L3T4 or Ly-2 antibodies.
    Mottram PL; Wheelahan J; McKenzie IF; Clunie GJ
    Transplant Proc; 1987 Apr; 19(2):2898-901. PubMed ID: 3105127
    [No Abstract]   [Full Text] [Related]  

  • 31. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered gene expression of cytokine, ICAM-1, and class II molecules precedes mouse intestinal allograft rejection.
    Quan D; Grant DR; Zhong RZ; Zhang Z; Garcia BM; Jevnikar AM
    Transplantation; 1994 Oct; 58(7):808-16. PubMed ID: 7940716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection.
    Johnson Z; Beilke J; Pietra B; Kelly B; Gill RG
    Transplant Proc; 2004 May; 36(4):1171-2. PubMed ID: 15194405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer T-cells participate in rejection of islet allografts in the liver of mice.
    Toyofuku A; Yasunami Y; Nabeyama K; Nakano M; Satoh M; Matsuoka N; Ono J; Nakayama T; Taniguchi M; Tanaka M; Ikeda S
    Diabetes; 2006 Jan; 55(1):34-9. PubMed ID: 16380474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rejection of established mouse pancreatic islet allografts by active immunization requires class I (H-2 K, D) antigen disparities.
    Morrow CE; Sutherland DE; Steffes MW; Najarian JS; Bach FH
    J Surg Res; 1984 Apr; 36(4):332-40. PubMed ID: 6423894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunologic consequence of class II+ pancreatic islet allografts on recipient responsiveness.
    Markmann JF; Barker CF; Lo D; Brinster R; Heber-Katz E; Naji A
    Transplant Proc; 1990 Aug; 22(4):2052-3. PubMed ID: 2143872
    [No Abstract]   [Full Text] [Related]  

  • 38. The alloimmune response to murine islets occurs via indirect antigen presentation to LYT2+ and L3T4+ lymphocytes.
    Stock PG; Ascher NL; Chen S; Bumgardner G; Field MJ; Sutherland DE
    Transplant Proc; 1990 Apr; 22(2):841-3. PubMed ID: 2183451
    [No Abstract]   [Full Text] [Related]  

  • 39. H-2 antigen class: effect on mouse islet allograft rejection.
    Morrow CE; Sutherland DE; Steffes MW; Najarian JS; Bach FH
    Science; 1983 Mar; 219(4590):1337-9. PubMed ID: 6402817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blockade of T-dependent major histocompatibility complex induction: a key immunosuppressive effect of cyclosporine.
    Autenried P; Halloran PF
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1184-5. PubMed ID: 3152623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.